12:13 PM EST, 12/16/2024 (MT Newswires) -- Hydreight Technologies ( HYDTF ) Monday updated its Direct-to-Consumer (D2C) healthcare platform, VSDHOne, which is now fully operational in all 50 U.S. states.

Hydreight ( HYDTF ) expects VSDHOne to generate significant recurring revenue, with over 200 licenses already onboarded and a projected 1,000 licenses by December, 2025.

The platform provides businesses with an end-to-end solution to launch their own healthcare brands, offering telemedicine, eCommerce, and pharmacy network capabilities.

The platform currently offers 40 products, including skincare, hair loss, and hormone replacement therapies, with plans to expand its offerings to include genetic testing and longevity-focused solutions.

"VSDHOne bridges the gap in healthcare accessibility, empowering nontraditional players to deliver personalized, convenient care directly to consumers," said chief executive Shane Madden. "This isn't just telemedicine; it's Telehealth 2.0."

Hydreight ( HYDTF ) shares were last seen down $0.04 to $1.03 on the TSX Venture Exchange.

Price: 1.04, Change: -0.03, Percent Change: -2.80